Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sivelestat in Acute Relapse of Neuromyelitis Optica Spectrum Disorder
NCT07738952Phase 2Recruiting
- Sponsor
- Kyushu University
- Start
- Oct 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 2 trial of sivelestat in Neuromyelitis Optica Spectrum Disorder (NMOSD), sponsored by Kyushu University. Started Oct 2026; status: recruiting.
02
Drugs
sivelestat
03
Conditions
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Beyond the preview
Go deeper on NCT07738952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07738952.